![](/img/cover-not-exists.png)
Phase II, double-blind, randomized trial of capecitabine plus enzastaurin versus capecitabine plus placebo in patients with metastatic or recurrent breast cancer after prior anthracycline and taxane therapy
Mark Clemons, Anil A. Joy, Radhi Abdulnabi, Mauricio Kotliar, Jodi Lynch, Johan P. Jordaan, Neill Iscoe, Karen GelmonVolume:
124
Language:
english
Pages:
10
DOI:
10.1007/s10549-010-1152-0
Date:
November, 2010
File:
PDF, 317 KB
english, 2010